Australia markets open in 2 hours 20 minutes

Crescita Therapeutics Inc. (CRRTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5000-0.0077 (-1.51%)
At close: 02:17PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.5077
Open0.5136
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.5000 - 0.5136
52-week range0.4000 - 0.7910
Volume46,000
Avg. volume4,132
Market cap11.076M
Beta (5Y monthly)2.45
PE ratio (TTM)N/A
EPS (TTM)-0.1040
Earnings date22 Mar 2022 - 28 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid

    LAVAL, Québec, December 15, 2021--Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") announced today that the Toronto Stock Exchange (the "TSX") has approved the Company’s renewal of its existing normal course issuer bid ("NCIB") for a portion of its common shares ("Common Shares") as appropriate opportunities arise from time to time.

  • Business Wire

    Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®

    LAVAL, Québec, December 13, 2021--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) ("Crescita"), a growth-oriented, innovation-driven Canadian commercial dermatology company, is pleased to announce that it has signed an exclusive commercialization and supply agreement with Egis Pharmaceuticals PLC ("Egis"), a leading generic pharmaceutical company in Central Eastern Europe (the "CEE") for the rights to Pliaglis in eight countries comprising: Hungary, Bulgaria, Czech Republic, Slovakia, Po

  • Business Wire

    Crescita Reports Third Quarter 2021 Results and Appoints New Board Member

    LAVAL, Quebec, November 11, 2021--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 2021 ("Q3-F2021"). All amounts presented are in thousands of Canadian dollars ("CAD") unless otherwise noted.